2
Registered trials
1
Recruiting
1
Unique sponsors
2
Unique IMPs
2
Commercial trials
Drug classes (ATC)
—
ATC code not specified
2
Mechanism of action (INN-stem analysis)
CAR-T cell therapy
1 substance
Monoclonal antibody
1 substance
Phase II:
2
Phase II
2 trials-
RecruitingNovartis Pharma AG CommercialRAPCABTAGENE AUTOLEUCEL
-
EndedNovartis Pharma AG CommercialIANALUMAB
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Novartis Pharma AG | Commercial | 2 | Phase II | 1 |
New trials by year
2024
1
2025
1